Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

merckincweb2

4D Pharma to collaborate with MSD in vaccine development

October 8, 2019 Manufacturing and Production

4D pharma, a leader in the development of live biotherapeutics, has announced it has entered into a research collaboration to …
News
national_multiple_sclerosis_society_move_it_

Multiple Sclerosis Society launches fundraising appeal to raise £100m

October 8, 2019 Manufacturing and Production

The MS Society has launched a hard-hitting public appeal to raise £100m to stop multiple sclerosis. The Stop MS Appeal …
News
novartis_outside_1

FDA approves Novartis’ Beovu injection for wet age-related macular degeneration

October 8, 2019 Manufacturing and Production, Sales and Marketing Beovu, Eylea, FDA, Novartis, Regeneron, pharma

Novartis has secured FDA approval for its Beovu (brolucizumab) injection in the treatment of wet age-related macular degeneration (AMD), it …
News

Pfizer to develop Akcea/Ionis’ Antisense Drug for up to $1.5bn

October 8, 2019 Manufacturing and Production

Pfizer and Akcea Therapeutics have entered into an exclusive worldwide licensing agreement for Akcea’s phase 2 cardiovascular and metabolic candidate …
News
merdad_parsey

Gilead appoints Merdad Parsey as Chief Medical Officer

October 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Gilead Sciences have announced that Merdad Parsey will join the company as Chief Medical Officer, effective November 1st. Dr Parsey …
Appointment

Breaking through limits in lung cancer: Introducing the Lung Ambition Alliance

October 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Lung Ambition Alliance, feature, lung cancer, pharma

Lung cancer kills more patients than any other variety of cancer, accounting for around a fifth of all cancer-related deaths …
Feature
department-of-health-social-care

Government issues first serious shortage protocol to combat lack of the antidepressant fluoxetine

October 3, 2019 Manufacturing and Production

The Department of Health and Social care has brought in measures to allow pharmacists to supply alternative strengths of fluoxetine …
News
sandrock-al-e1548286908776

Biogen announces leadership updates

October 2, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Biogen have announced updates to it senior leadership team with Alfred Sandrock being named Executive Vice President of Research and …
Appointment
dave_peacock

MSD announce David Peacock as new Managing Director in UK and Ireland

October 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

MSD have announced that David Peacock will become Managing Director in the UK and Ireland, succeeding former director Louise Houson, …
Appointment

Sanofi’s Jevtana doubles progression-free survival in metastatic castration-resistant prostate cancer

October 1, 2019 Manufacturing and Production, Research and Development ESMO 2019, Jevtana, Sanofi, pharma, prostate cancer

Sanofi was present at the 2019 European Society of Medical Oncology (ESMO) Congress in Barcelona this year to reveal new …
News

Chris Whitty begins role as England’s Chief Medical Officer

October 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

London consultant and public health professor, Chris Whitty, has begun his role as England’s Chief Medical Officer, taking over from …
Appointment
roche__tree

Roche’s Tecentriq plus chemo shows promise in first-line, advanced bladder cancer

October 1, 2019 Manufacturing and Production, Research and Development Cancer, ESMO 2019, Roche, breast cancer, pharma, tecentriq

Roche has revealed data from an interim analysis of its immunotherapy Tecentriq (atezolizumab) at the 2019 European Society for Medical …
News
lynparza

AZ and MSD’s parp inhibitor Lynparza cuts risk of progression and death in prostate cancer

October 1, 2019 Manufacturing and Production

AstraZeneca and MSD have shown in their Phase 3 PROfound trial, PARP inhibitor Lynparza (olaparib) reduced the risk of disease …
News
Sobi Logo

Sobi to acquire Dova for $915m to broaden hematology franchise

October 1, 2019 Manufacturing and Production

Sobi is to buy Dova Pharmaceuticals for $915 million in a bid to grow Sobi’s hematology portfolio, with liver cancer …
News
10257-itokwqzqhdt9

ESMO studies show CD4K/6 inhibitor and fulvestrant improves OS in breast cancer

October 1, 2019 Manufacturing and Production

Detailed findings from two Phase III trials presented at the European Society for Medical Oncology showed that treatment with a …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026